StockPriceToday
Coca-Cola Europacific Partners PLC (CCEP)
About Coca-Cola Europacific Partners PLC
Coca-Cola Europacific Partners PLC operates as one of the largest independent Coca-Cola bottlers worldwide, producing and distributing nonalcoholic beverages across Europe, Australia, and the Pacific region. The company's role as a Coca-Cola bottler has made CCEP stock price sensitive to beverage consumption trends and regional economic conditions.
CCEP's product portfolio includes Coca-Cola, Sprite, Fanta, and various other brands along with water, sports drinks, and juice products that serve diverse consumer preferences. The company's distribution network reaches millions of customers through retail stores, restaurants, and vending machines.
The company's manufacturing and distribution capabilities enable efficient production and delivery across its geographic markets while its customer relationships provide access to various sales channels. CCEP's focus on sustainability and product innovation aligns with changing consumer preferences, affecting CCEP stock price trends.
CCEP's partnership with The Coca-Cola Company provides brand strength and marketing support while its operational expertise enables efficient market execution. The company's ability to adapt to local market conditions while leveraging global brand recognition remains important for its continued growth and market leadership.
CCEP Stock 12 Month Chart
Latest News for CCEP
UBS set a USD 107.00 target with Neutral on October 5, 2026. Coca-Cola Europacific Partners stock costs EUR 90.80 on October 8, 2026 after EUR 89.40.
View Coca-Cola Europacific Partners plc CCEP stock quote prices, financial information, real-time forecasts, and company news from CNN.
Detailed price information for Coca-Cola Europacific Partners Plc (CCEP-Q) from The Globe and Mail including charting and trades.
Other Popular Stocks
eBay Inc. (EBAY) is a global e-commerce marketplace that connects millions of buyers and sellers worldwide, facilitating transactions across diverse product categories and price...
Voyager Therapeutics Inc. (VYGR) is a clinical-stage biotechnology company developing gene therapies for severe neurological diseases, focusing on adeno-associated virus (AAV) vector technologies to...
Option Care Health Inc. (OPCH) is a healthcare services company providing home and alternate site infusion therapy, specialty pharmacy services, and clinical support for...